Peptron, Inc.
KOSDAQ 087010.KQ
Peptron, Inc. Market Capitalization on January 14, 2025: USD 1.43 B
Peptron, Inc. Market Capitalization is USD 1.43 B on January 14, 2025, a 164.70% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Peptron, Inc. 52-week high Market Capitalization is USD 2.17 B on November 15, 2024, which is 51.26% above the current Market Capitalization.
-
Peptron, Inc. 52-week low Market Capitalization is USD 370.47 M on April 17, 2024, which is -74.15% below the current Market Capitalization.
-
Peptron, Inc. average Market Capitalization for the last 52 weeks is USD 923.07 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
KOSDAQ: 087010.KQ
| CEO | Mr. Ho-Il Choi |
| IPO Date | July 22, 2015 |
| Location | South Korea |
| Headquarters | 37-24, Yuseong-daero 1628 beon-gil |
| Employees | 94 |
| Sector | Health Care |
| Industries | |
Description
Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email